MeSH D018461 - soft tissue infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Dalbavancin | Xydalba |  | 2015-02-19 |  |  |
| Accord Healthcare | Tigecycline | Tigecycline Accord |  | 2020-04-17 |  |  |
| Alembic Pharmaceuticals | Linezolid | Linezolid |  | 2015-12-21 |  |  |
| Alkem Laboratories | Linezolid | Linezolid |  | 2015-12-21 |  |  |
| Cephalexin | Cephalexin |  | 2010-12-20 |  |  |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
40%2/5
Phase 3
87%47/54
Approved: 44Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use